Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Jan 19;102(2):447-54.
doi: 10.1038/sj.bjc.6605338. Epub 2009 Nov 17.

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

Affiliations
Multicenter Study

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

I P M Tomlinson et al. Br J Cancer. .

Erratum in

  • Br J Cancer. 2010 Jan 19;102(2):455. Niittymäkix, I [corrected to Niittymäki, I]; Tuupanenx, S [corrected to Tuupanen, S]

Abstract

It is now recognised that a part of the inherited risk of colorectal cancer (CRC) can be explained by the co-inheritance of low-penetrance genetic variants. The accumulated experience to date in identifying these variants has served to highlight difficulties in conducting statistically and methodologically rigorous studies and follow-up analyses. The COGENT (COlorectal cancer GENeTics) consortium includes 20 research groups in Europe, Australia, the Americas, China and Japan. The overarching goal of COGENT is to identify and characterise low-penetrance susceptibility variants for CRC through association-based analyses. In this study, we review the rationale for identifying low-penetrance variants for CRC and our proposed strategy for establishing COGENT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Polygenic model of colorectal cancer susceptibility. (A) Distribution of risk alleles for CRC, cases (black bars) and controls (grey bars); (B) Plot of the increasing ORs for CRC with increasing number of risk alleles. The ORs are relative to the median number of risk alleles; Vertical bars correspond to 95% confidence intervals. Data from Houlston et al (2008).

References

    1. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R (2007) Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 13: 356–361 - PubMed
    1. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O, Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39: 1315–1317 - PubMed
    1. Castells A, Andreu M (2007) EPICOLON project: contribution to the knowledge of Lynch syndrome and other familial or hereditary colorectal cancer. Med Clin (Barc) 128: 55–60 - PubMed
    1. Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M (2006) NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 979–987 - PubMed
    1. Chen K, Jiang QT, He HQ (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11: 331–335 - PMC - PubMed

Publication types